Skip to Main Content

Paper Details

Managing adverse events of sacituzumab govitecan.
Expert Opin Biol Ther
2
2023
Author NameAffiliation
Sara M TolaneyDana-Farber Cancer Institute
Sara M TolaneyDana-Farber Brigham Cancer Center
Sara M TolaneyHarvard Medical School
  • 1 - 3

Datasets

Release 1.2